Clients of genetic data company 23andMe may be at greater risk than they realize, notes A New York Times story This argues that the company’s problems could be short-term compared to the long-term threats facing its roughly 15 million people if 23andMe cannot continue as a going concern.
Certainly, founder and CEO Anne Wojcicki’s hope of turning around 23andMe seems increasingly distant. Follow a Big breach And resignation block From its independent directors, the company, once worth $6 billion, is now worth $150 million. It’s about to be It has been deleted Next month. Newspaper stories Doesn’t help. (Will you buy one of her DNA kits?)
The company says it remains committed to “following the laws governing the data we collect,” but if it can’t do so sometime soon, that’s worrisome, a Yale biomedical professor tells the Times. He points out that hacked credit cards can be replaced, while genomes cannot. At the same time, he adds, technology that analyzes genomes is advancing. It will probably become more revealing as well.
Comments are closed, but trackbacks and pingbacks are open.